Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), S1925

Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with CLL/SLL

Breast, NRG-BR007

DEBRA-De-escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18

Breast, CELC-G-301

Viktoria-1 Gedatolisib in Combination with Palbociclib and Fulvestrant Compared to SOC in Previously Treated Pts with HR-Positive, HER2 Negative Advanced Breast Cancer

February's "Cancer News from HOA" on 93Q with Amy Robbins: Dr. Gajra discusses the latest in immunotherapy

Dr. Gajra talks about the latest in Immunotherapy when it comes to cancer treatment in February’s interview below.

Patient Newsletter 2023 February

Bile Duct Cancers

Patient Newsletter 2023 January

Young Women with Breast Cancer Support Group For women in their 20s, 30s, 40s

5-6pm on Wednesdays January 11 - February 15, 2023.   

At Hematology Oncology Associates of CNY
5008 Brittonfield Parkway
East Syracuse, NY 13057

Please register by emailing or calling Pamela Coffey, 472-7504 ext 1608 or pcoffey@hoacny.com

Patient Newsletter 2022 December

Hematology-Oncology Associates of CNY Achieves Accreditation for Radiation Oncology Services from ASTRO's APEx – Accreditation Program for Excellence®

East Syracuse, NY — Hematology-Oncology Associates of CNY (HOA) successfully attained accreditation from the American Society for Radiation Oncology (ASTRO) APEx - Accreditation Program for Excellence®. APEx provides external validation that a radiation oncology facility is delivering high-quality patient care. HOA’s accreditation is effective through November 2026.

Pages